Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Prażmo, , Aniela,
DOB: 08-FEB-1941 (Age: 84)
Gender: female
Address:
pl. Kołłątaja 62/43
97-200 Tomaszów Mazowiecki (Poland)
ID: 9657-869171-7 (ECI)
Report
Date: 25-MAY-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Poradnia rehabilitacyjna
97-200 Tomaszów Mazowiecki (Poland)
Specimen
Collected: 25-MAY-2017

Hematology

Test 25-MAY-2017 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 6.9 4 - 11 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 5.4 3.8 - 5.7 10*6/uL
Hemoglobin [Mass/volume] in Blood 12.3 12 - 16 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 43.2 38 - 56 %
MCV [Entitic volume] by Automated count 94.3 78 - 98 fL
MCH [Entitic mass] by Automated count 31.1 27 - 34 pg
MCHC [Mass/volume] by Automated count 34.4 32 - 35 g/dL
Erythrocyte distribution width [Ratio] by Automated count 14.5 11.6 - 16.5 %
Platelets [#/volume] in Blood by Automated count 220.3 157 - 415 10*3/uL

Chemistry

Test 25-MAY-2017 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 71.5 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 7.8 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 2.8 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.7 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Serum or Plasma 136.6 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 4.3 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 105.0 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 23.3 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 8.1 6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.7 3.5 - 5 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 9.5 H 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 82.6 32 - 150 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18.3 13 - 32 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19.3 10 - 40 U/L
Magnesium [Mass/volume] in Serum or Plasma 1.7 1.7 - 2.6 mg/dL
Phosphate [Mass/volume] in Serum or Plasma 2.8 2.5 - 4.5 mg/dL
pH of Arterial blood 7.1 L 7.35 - 7.45 [pH]
Carbon dioxide [Partial pressure] in Arterial blood 36.7 L 38 - 48 mm[Hg]
Oxygen [Partial pressure] in Arterial blood 92.7 75 - 100 mm[Hg]
Bicarbonate [Moles/volume] in Arterial blood 25.1 22 - 31 mmol/L
Oxygen saturation in Arterial blood 94.0 L 95 - 100 %
Cholesterol [Mass/volume] in Serum or Plasma 299.5 H 130 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 140.8 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 210.5 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 60.9 50 - 100 mg/dL

Coagulation

Test 25-MAY-2017 Reference Range Unit
Prothrombin time (PT) 10.5 L 11 - 15 s
INR in Platelet poor plasma by Coagulation assay 1.1 0.9 - 1.1 {INR}
aPTT in Blood by Coagulation assay 25.7 25 - 35 s

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significant renal dysfunction (elevated creatinine), marked hyperbilirubinemia, metabolic acidosis (low pH, low pCO₂, low O₂ saturation), and dyslipidemia (high total and LDL cholesterol). Other parameters, including blood count and liver enzymes, are within normal limits. These findings suggest acute or chronic kidney and possible hepatobiliary dysfunction, with increased cardiovascular risk. Immediate clinical correlation and further evaluation are recommended.